United States · Series C startup

Who invested in BigHat Biosciences

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotech

Raised 1 month ago

Funding summaryUpdated 26 Oct 2026

$150Mraised across 2 rounds since 2022, from 2 sources

$75MSeries B$75MSeries C
Latest round
Series C, $75MSept 2026
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2023202420252026
$75MSeries B$75MSeries C
First round
Series B, $75M
Jul 2022
Biggest round
$75M
Series C · Sept 2026
Between rounds
4.2 years
from the last two

The rounds

  1. Sept 2026
  2. Jul 2022
    Series B$75M4 new

    Reported by Quadrille CapitalSEC filing: $80M sold, first sale Jun 2022

Founders and team

From BigHat Biosciences's own website: 1 founder, 34 on the team.

Peyton GreensideCEO & Co-Founder
  • Eddie AbramsChief Information Officer
  • John CorbinChief Development Officer
  • Liz SchwarzbachChief Business Officer
  • Stefan WeigandChief Scientific Officer
  • Brett WeinsteinVP, Finance
  • Charbel EidVP, Platform
  • Aaron SolomonAssociate Director, Computational Platform
  • Amgen’ Golden TicketPartner
  • Anisha KeshavanPrincipal Data Scientist
  • Annalisa SharkeyProduct Manager II
  • Cameron CordayAssociate Scientist
  • Crystal HumphriesPrincipal Data Scientist
  • Dan AndersonSenior Software Engineer II
  • Danielle BarrerasAssociate Scientist
  • Eman KhanSenior Research Associate
  • Emma ScaffResearch Associate I
  • Eva BoettcherAssociate Scientist
  • Helena FuAssociate Scientist

And 16 more on the team.

AdvisersMark DePristoStanley LapidusTheresa Tribble

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Andreessen HorowitzVC firm2rounds
8VCVC firm2rounds
S32VC firm2rounds
GaingelsPrivate equity1round
Eli LillyCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list BigHat Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Flucas VenturesAngel networkPer its own site
Walker Street CapitalVC firmPer its own site

Quick answers about BigHat Biosciences

Who invested in BigHat Biosciences?

BigHat Biosciences's investors include Andreessen Horowitz, 8VC, S32, Gaingels and Eli Lilly, and 1 more on record.

How much has BigHat Biosciences raised?

BigHat Biosciences has raised $150M across 2 rounds since 2022.

When did BigHat Biosciences last raise?

BigHat Biosciences's most recent round was a Series C of $75M in Sept 2026.

What was BigHat Biosciences's biggest round?

Its most recent round, $75M in Sept 2026, is also its largest on record.

Who backed BigHat Biosciences first?

BigHat Biosciences's first round on record, in Jul 2022, was backed by Andreessen Horowitz, Gaingels and 8VC and 1 others.

What stage is BigHat Biosciences at?

BigHat Biosciences's latest named round is a Series C, in Sept 2026.

Where is BigHat Biosciences based?

BigHat Biosciences is based in the United States.

Companies like BigHat Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.